Stay updated on SB2 vs Remicade in RA Clinical Trial.
Sign up to get notified when there's something new on the SB2 vs Remicade in RA Clinical Trial. page.

Latest updates to the SB2 vs Remicade in RA Clinical Trial. page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include the term 'Rheumatoid Arthritis' and the study identifier 'SB2-G31-RA', while the previous detailed study description and inclusion/exclusion criteria have been removed. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to SB2 vs Remicade in RA Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the SB2 vs Remicade in RA Clinical Trial. page.